These CD103+CD69+CD8+ TRM cells may correspond to truly tumour-reactive T cells the differentiation of which is associated with TGF-β that might be activated in the TME by a mechanism dependent of MMP on tumour cells or αV integrins on immune cells. The gene discussed is CD8A; the disease is neoplasm.